2-nitrophenylgalactoside has been researched along with rifampin in 2 studies
Studies (2-nitrophenylgalactoside) | Trials (2-nitrophenylgalactoside) | Recent Studies (post-2010) (2-nitrophenylgalactoside) | Studies (rifampin) | Trials (rifampin) | Recent Studies (post-2010) (rifampin) |
---|---|---|---|---|---|
95 | 0 | 21 | 20,468 | 1,499 | 6,552 |
Protein | Taxonomy | 2-nitrophenylgalactoside (IC50) | rifampin (IC50) |
---|---|---|---|
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.949 | |
Caspase-1 | Homo sapiens (human) | 8.319 | |
Alpha-synuclein | Homo sapiens (human) | 7.1 | |
Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 0.03 | |
DNA-directed RNA polymerase subunit beta | Mycobacterium tuberculosis H37Rv | 0.01 | |
Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.5 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ciccaglione, AR; Costantino, A; Equestre, M; Geraci, A; Marcantonio, C; Rapicetta, M | 1 |
Baker, KR; Franzyk, H; Guardabassi, L; Jana, B | 1 |
2 other study(ies) available for 2-nitrophenylgalactoside and rifampin
Article | Year |
---|---|
Hepatitis C virus E1 protein induces modification of membrane permeability in E. coli cells.
Topics: Bacteriolysis; Cell Membrane; Cell Membrane Permeability; Cloning, Molecular; Coloring Agents; Escherichia coli; Nitrophenylgalactosides; Nucleic Acid Synthesis Inhibitors; Peptide Fragments; Propidium; Rifampin; Viral Envelope Proteins | 1998 |
A High-Throughput Approach To Identify Compounds That Impair Envelope Integrity in Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Galactosidase; beta-Lactamases; Biological Transport; Cell Wall; Chromogenic Compounds; Erythromycin; Escherichia coli; Fusidic Acid; Gene Expression; High-Throughput Screening Assays; Hydrolysis; Microbial Sensitivity Tests; Mutation; Nitrophenylgalactosides; Novobiocin; Peptide Library; Peptides; Peptidomimetics; Permeability; Rifampin | 2016 |